Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy

Annals of Neurology

Volumn 67, Issue 1, 2010, Pages 53-63

  Salajegheh, Mohammad ^a   Kong, Sek Won ^a   Pinkus, Jack L ^a   Walsh, Ronan J ^a   Liao, Anne ^a   Nazareno, Remedios ^a   Amato, Anthony A ^a   Krastins, Bryan ^b   Morehouse, Chris ^c   Higgs, Brandon W ^c   Jallal, Bahija ^c   Yao, Yihong ^c   Sarracino, David A ^b   Parker, Kenneth C ^a,b   Greenberg, Steven A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LABORATORY FOR MOLECULAR MEDICINE   (United States)

^c MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CONNECTIN; CYTOKINE; INTERFERON;

ADULT; ARTICLE; CONJUGATION; CONTROLLED STUDY; DERMATOMYOSITIS; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERFERON STIMULATED GENE 15; MAJOR CLINICAL STUDY; MUSCLE ATROPHY; MUSCLE BIOPSY; PERIFASCICULAR ATROPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

CELLS, CULTURED; CYTOKINES; DATABASES, GENETIC; DERMATOMYOSITIS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE I; LASERS; MICRODISSECTION; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROTEIN KINASES; PROTEOMICS; SENSITIVITY AND SPECIFICITY; UBIQUITINS; UP-REGULATION;

EID: 77649298737     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21805     Document Type: Article

References (42)

1. Greenberg SA, Pinkus JL, Pinkus GS, et al. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 2005;57:664-678.
2. Wenzel J, Schmidt R, Proelss J, et al. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol 2006;31:576-582.
3. Yuan W, Krug RM. In.uenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. Embo J 2001;20:362-371.
4. Zhao C, Beaudenon SL, Kelley ML, et al. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc Natl Acad Sci U S A 2004; 101:7578-7582.
5. Dastur A, Beaudenon S, Kelley M, et al. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem 2006;281:4334-4338.
6. Wong JJ, Pung YF, Sze NS, Chin KC. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci U S A 2006; 103:10735-10740.
7. Malakhov MP, Malakhova OA, Kim KI, et al. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem 2002;277:9976-9981.
8. Zhao C, Denison C, Huibregtse JM, et al. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 2005;102:10200-10205.
9. Desai SD, Haas AL, Wood LM, et al. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res 2006;66:921-928.
10. Walsh RJ, Kong SW, Yao Y, et al. Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum 2007;56: 3784-3792.
11. Greenberg SA, Sanoudou D, Haslett JN, et al. Molecular profiles of inflammatory myopathies. Neurology 2002;59:1170-1182.
12. Wu Z, Irizarry RA. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J Comput Biol 2005;12: 882-893.
13. Yao Y, Richman L, Higgs BW, et al. Neutralization of interferon-alpha/ beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum 2009;60:1785-1796.
14. Parker KC, Kong SW, Walsh RJ, et al. Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis. Muscle Nerve 2009;39:739-753.
15. Bakay M, Wang Z, Melcon G, et al. Nuclear envelope dystrophies show a transcriptional .ngerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain 2006;129: 996-1013.
16. Chen YW, Shi R, Geraci N, et al. Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis. BMC Immunol 2008;9:43.
17. Banker BQ. Dermatomyostis of childhood, ultrastructural alteratious of muscle and intramuscular blood vessels. J Neuropathol Exp Neurol 1975;34:46-75.
18. Carpenter S, Karpati G, Rothman S, Watters G. The childhood type of dermatomyositis. Neurology 1976;26:952-962.
19. De Visser M, Emslie-Smith AM, Engel AG. Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle. J Neurol Sci 1989;94: 181-192.
20. Grimley PM, Davis GL, Kang YH, et al. Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon. Lab Invest 1985;52:638-649.
21. Grimley PM, Rutherford MN, Kang YH, et al. Formation of tubuloreticular inclusions in human lymphoma cells compared to the induction of 2-5-oligoadenylate synthetase by leucocyte interferon in dose-effect and kinetic studies. Cancer Res 1984;44: 3480-3488.
22. Kuyama J, Kanayama Y, Mizutani H, et al. Formation of tubuloreticular inclusions in mitogen-stimulated human lymphocyte cultures by endogenous or exogenous alpha-interferon. Ultrastruct Pathol 1986;10:77-85.
23. Norton WL, Velayos E, Robison L. Endothelial inclusions in dermatomyositis. Ann Rheum Dis 1970;29:67-72.
24. Rich SA. Human lupus inclusions and interferon. Science 1981; 213:772-775.
25. Rich SA, Owens TR, Bartholomew LE, Gutterman JU. Immune interferon does not stimulate formation of alpha and beta interferon induced human lupus-type inclusions. Lancet 1983;1: 127-128.
26. D'Cunha J, Knight E Jr, Haas AL, et al. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A 1996;93:211-215.
27. Recht M, Borden EC, Knight E Jr. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol 1991; 147:2617-2623.
28. Loeb KR, Haas AL. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem 1992; 267:7806-7813.
29. Giannakopoulos NV, Luo JK, Papov V, et al. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 2005;336:496-506.
30. Pitha-Rowe I, Hassel BA, Dmitrovsky E. Involvement of UBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia. J Biol Chem 2004;279:18178-18187.
31. Hamerman JA, Hayashi F, Schroeder LA, et al. Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog. J Immunol 2002;168:2415-2423.
32. Malakhov MP, Kim KI, Malakhova OA, et al. High-throughput immunoblotting. Ubiquitin-like protein ISG15 modifies key regulators of signal transduction. J Biol Chem 2003;278:16608-16613.
33. Ritchie KJ, Malakhov MP, Hetherington CJ, et al. Dysregulation of protein modification by ISG15 results in brain cell injury. Genes Dev 2002;16:2207-2212.
34. Greenberg SA, Fiorentino D. Similar topology of injury to keratinocytes and myofibers in dermatomyositis skin and muscle. Br J Derm 2009;160:464-465.
35. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-982.
36. Greenberg SA. Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications. Neurology 2007;69:2008-2019.
37. Parker KC, Walsh RJ, Salajegheh M, et al. Characterization of human skeletal muscle biopsy samples using shotgun proteomics. J Proteome Res 2009;8:3265-3277.
38. Gregorio CC, Granzier H, Sorimachi H, Labeit S. Muscle assembly: a titanic achievement? Curr Opin Cell Biol 1999;11:18-25.
39. Peng J, Raddatz K, Labeit S, et al. Muscle atrophy in titin M-line deficient mice. J Muscle Res Cell Motil 2005;26:381-388.
40. Peterson KS, Huang JF, Zhu J, et al. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional pro.les of laser-captured glomeruli. J Clin Invest 2004;113:1722-1733.
41. Bennett L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003;197:711-723.
42. Yao Y, Higgs BW, Morehouse C, et al. Development of potential pharmacodynamic and diagnostic markers for anti-IFNalpha monoclonal antibody trials in systemic lupus erythematosus. Human Genomics and Proteomics 2009. Article ID: 374312.